The Association of Cardiac Valve Calcification and 1-year Mortality After Lower-extremity Amputation in Diabetic Patients

Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Other)
Overall Status
Completed
CT.gov ID
NCT06079008
Collaborator
(none)
96
72

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about the association between cardiac valve calcification and the 1-year mortality after lower-extremity amputation in diabetic patients. Diabetic patients requiring lower-extremity amputation were retrospectively studied. Preoperative detailed anamnesis was taken. Cardiac valve calcification was assessed using echocardiography at baseline. One-year follow-up was conducted and included clinical visits, hospital record assessment, and telephone reviews to obtain the survival status of patients. Researchers compare the survival group to the mortality group to study the relationship between the cardiac valve calcification and mortality.

Condition or Disease Intervention/Treatment Phase
  • Other: calcified cardiac valve

Detailed Description

This study aimed to investigate the association between cardiac valve calcification and 1-year mortality in diabetic patients after lower-extremity amputation. The investigator recruited consecutive patients who were admitted to the Sun Yat-sen Memorial Hospital for diabetic foot ulcers that needed amputation surgery. Clinical characteristics of each patient and the laboratory examination were collected before surgery. Cardiac valve calcification was assessed at baseline. This study obtained the survival status of patients within one year through outpatient follow-up and telephone follow-up. Researchers compared the survival group to the mortality group to see if the mortality group had a higher prevalence of heart valve calcification.

Study Design

Study Type:
Observational
Actual Enrollment :
96 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
The Association of Cardiac Valve Calcification and 1-year Mortality After Lower-extremity Amputation in Diabetic Patients: a Retrospective Study
Actual Study Start Date :
Jun 1, 2016
Actual Primary Completion Date :
Jun 1, 2022
Actual Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
survival group

The patients who survived more than 1-year after amputation surgery.

Other: calcified cardiac valve
patients have cardiac cardiac valve before surgery

mortality group

The patients who were dead within 1-year after amputation surgery.

Other: calcified cardiac valve
patients have cardiac cardiac valve before surgery

Outcome Measures

Primary Outcome Measures

  1. The proportion of cardiac valve calcification between survival group and mortality group [2017-12-1]

    The prevalence of calcified heart valve diseases was compared between the mortality group and survival group.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Had echocardiography at baseline

  • With diabetic foot ulcers that required amputation after orthopedist's assessment

Exclusion Criteria:
  • Fractures due to traumatic reasons that required extremity amputation

  • Amputation level below the ankle

  • Severe sepsis that required vasoactive agent treatment

  • Rheumatic heart disease

  • Heart valve surgery history

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
ClinicalTrials.gov Identifier:
NCT06079008
Other Study ID Numbers:
  • SYSKY-2022-035-01
First Posted:
Oct 12, 2023
Last Update Posted:
Oct 12, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2023